p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells
- PMID: 24367162
- PMCID: PMC3022348
- DOI: 10.2147/bctt.s6255
p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells
Abstract
Elevated Src tyrosine kinase activity is commonly observed in breast cancer and likely contributes to neoplasia and malignancy. p130Cas ("Crk-associated substrate") is a major Src substrate found at the sites where integrins mediate cell adhesion to the extracellular matrix. Src phosphorylates multiple tyrosines in the p130Cas "substrate domain" (SD) and this signaling event has been implicated in the promotion of cell motility, primarily from studies on fibroblasts. In breast cancer, studies on p130Cas have focused on its role in conferring antiestrogen resistance to cells that express the estrogen receptor (ER+). However, little is known regarding the role of p130Cas in the more aggressive estrogen receptor negative (ER-) breast cancers for which there is a need for development of effective targeted therapies. We found high levels of p130Cas SD tyrosine phosphorylation to be a common characteristic of ER- breast cancer cell lines, with particularly high levels observed for the BT-549 cell line. Using RNA interference to knock down p130Cas expression in BT-549 cells, combined with rescue by WT p130Cas versus a signaling-deficient control, we provide evidence that p130Cas SD tyrosine phosphorylation is an important signaling event in the migration, invasion, proliferation, and survival of this ER-breast cancer cell line.
Keywords: BCAR1; FAK; Src; adhesion; integrins; tyrosine phosphorylation.
Figures








Similar articles
-
Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.Oncogene. 2006 Dec 7;25(58):7597-607. doi: 10.1038/sj.onc.1209747. Epub 2006 Jun 26. Oncogene. 2006. PMID: 16799644
-
Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.Mol Cell Biol. 1997 Mar;17(3):1702-13. doi: 10.1128/MCB.17.3.1702. Mol Cell Biol. 1997. PMID: 9032297 Free PMC article.
-
Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities.J Biol Chem. 2015 May 8;290(19):12247-55. doi: 10.1074/jbc.M115.649947. Epub 2015 Mar 24. J Biol Chem. 2015. PMID: 25805500 Free PMC article.
-
p130Cas/BCAR1 and p140Cap/SRCIN1 Adaptors: The Yin Yang in Breast Cancer?Front Cell Dev Biol. 2021 Oct 11;9:729093. doi: 10.3389/fcell.2021.729093. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34708040 Free PMC article. Review.
-
p130Cas: a key signalling node in health and disease.Cell Signal. 2013 Apr;25(4):766-77. doi: 10.1016/j.cellsig.2012.12.019. Epub 2012 Dec 29. Cell Signal. 2013. PMID: 23277200 Review.
Cited by
-
Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.Carcinogenesis. 2013 Dec;34(12):2880-90. doi: 10.1093/carcin/bgt238. Epub 2013 Jul 3. Carcinogenesis. 2013. PMID: 23825155 Free PMC article.
-
P130Cas Src-binding and substrate domains have distinct roles in sustaining focal adhesion disassembly and promoting cell migration.PLoS One. 2010 Oct 18;5(10):e13412. doi: 10.1371/journal.pone.0013412. PLoS One. 2010. PMID: 20976150 Free PMC article.
-
Roles for crk in cancer metastasis and invasion.Genes Cancer. 2012 May;3(5-6):334-40. doi: 10.1177/1947601912458687. Genes Cancer. 2012. PMID: 23226571 Free PMC article.
-
Ephrin-Bs Drive Junctional Downregulation and Actin Stress Fiber Disassembly to Enable Wound Re-epithelialization.Cell Rep. 2015 Nov 17;13(7):1380-1395. doi: 10.1016/j.celrep.2015.09.085. Epub 2015 Nov 5. Cell Rep. 2015. PMID: 26549443 Free PMC article.
-
Light-regulated allosteric switch enables temporal and subcellular control of enzyme activity.Elife. 2020 Sep 23;9:e60647. doi: 10.7554/eLife.60647. Elife. 2020. PMID: 32965214 Free PMC article.
References
-
- Frame MC. Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta. 2002;1602(2):114–130. - PubMed
-
- Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003;22(4):337–358. - PubMed
-
- Playford MP, Schaller MD. The interplay between Src and integrins in normal and tumor biology. Oncogene. 2004;23(48):7928–7946. - PubMed
-
- Mayer BJ, Hamaguchi M, Hanafusa H. A novel viral oncogene with structural similarity to phospholipase C. Nature. 1988;332(6161):272–275. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous